BusinessMoseda Announces Paid Pilot with Florida, USA based Sacred Heart Health SystemBy Nasdaq OMXApr 4, 2016, 8:00 AM UTC
BusinessPeregrine Pharmaceuticals Reports Financial Results for Third Quarter of Fiscal Year 2016 and Recent DevelopmentsBy Nasdaq OMXMar 9, 2016, 1:00 PM UTC
BusinessPeregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred StockBy Nasdaq OMXMar 7, 2016, 9:05 PM UTC
BusinessPeregrine Pharmaceuticals Announces Formal Commissioning of New, State-of-the-Art Commercial Manufacturing FacilityBy Nasdaq OMXMar 7, 2016, 1:05 PM UTC
BusinessPeregrine to Report Financial Results for Third Quarter of Fiscal Year 2016 Prior to Market Open on March 9, 2016By Nasdaq OMXMar 3, 2016, 9:05 PM UTC
BusinessAREVA Med Partners With Art Institute of Dallas (U.S.) and École Supérieure de Design Troyes (France)By Nasdaq OMXFeb 29, 2016, 6:30 PM UTC
BusinessPeregrine Pharmaceuticals Provides Update on Phase III SUNRISE Trial of BavituximabBy Nasdaq OMXFeb 25, 2016, 9:05 PM UTC
BusinessImmune Design Announces Positive Topline Data From Three Phase 1 Clinical Trials of Immuno-oncology Product CandidatesBy Nasdaq OMXFeb 9, 2016, 1:00 PM UTC
